Antigen-Bound and Free β-Amyloid Autoantibodies in Serum of Healthy Adults

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Maftei, Madalina ^a   Thurm, Franka ^a,b   Leirer, Vera Maria ^a   von Arnim, Christine A F ^b   Elbert, Thomas ^a   Przybylski, Michael ^a   Kolassa, Iris Tatjana ^a,b   Manea, Marilena ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; COGNITION; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PSYCHOLOGIC TEST; TASK PERFORMANCE; VISUAL MEMORY; VOLUNTEER; WECHSLER INTELLIGENCE SCALE; WORD RECOGNITION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MOLECULAR SEQUENCE DATA; NEUROPSYCHOLOGICAL TESTS;

EID: 84866015162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044516     Document Type: Article

References (41)

1. Bäckman L, Wahlin Å, Small BJ, Herlitz A, Winblad B, et al. (2004) Cognitive Functioning in Aging and Dementia: The Kungsholmen Project. Aging Neuropsychol Cogn 11: 212-244.
2. Corral M, Rodríguez M, Amenedo E, Sánchez JL, Díaz F, (2006) Cognitive reserve, age, and neuropsychological performance in healthy participants. Dev Neuropsychol 29: 479-491.
3. Leirer VM, Wienbruch C, Kolassa S, Schlee W, Elbert T, et al. (2011) Changes in cortical slow wave activity in healthy aging. Brain Imaging Behav 5: 222-228.
4. Christensen H, (2001) What cognitive changes can be expected with normal ageing? Aust N Z J Psychiatry 35: 768-775.
5. Salthouse TA, (2009) When does age-related cognitive decline begin? Neurobiol Aging 30: 507-514.
6. Weng N-P, (2006) Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24: 495-499.
7. Bürkle A, Caselli G, Franceschi C, Mariani E, Sansoni P, et al. (2007) Pathophysiology of ageing, longevity and age related diseases. Immun Ageing 4: 4.
8. Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, et al. (2005) Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease? J Psychiatr Res 39: 535-543.
9. Jolles S, Sewell WAC, Misbah SA, (2005) Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 142: 1-11.
10. Du Y, Wei X, Dodel R, Sommer N, Hampel H, et al. (2003) Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity. Brain 126: 1935-1939.
11. Dodel R, Balakrishnan K, Keyvani K, Deuster O, Neff F, et al. (2011) Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease. J Neurosci 31: 5847-5854.
12. Dodel R, Neff F, Noelker C, Pul R, Du Y, et al. (2010) Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence. Drugs 70: 513-528.
13. Relkin NR, Szabo P, Adamiak B, Burgut T, Monthe C, et al. (2009) 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging 30: 1728-1736.
14. Brettschneider S, Morgenthaler NG, Teipel SJ, Fischer-Schulz C, Bürger K, et al. (2005) Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. Biol Psychiatry 57: 813-816.
15. Du Y, Dodel R, Hampel H, Buerger K, Lin S, et al. (2001) Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology 57: 801-805.
16. Song M, Mook-Jung I, Lee H, Min J, Park M, (2007) Serum anti-amyloid-beta antibodies and Alzheimer 's disease in elderly Korean patients. J Int Med Res 35: 301-306.
17. Weksler ME, Relkin N, Turkenich R, Larusse S, Ling Z, et al. (2002) Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals. Exp Gerontol 37: 943-948.
18. Mruthinti S, Buccafusco JJ, Hill WD, Waller JL, Jackson TW, et al. (2004) Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol Aging 25: 1023-1032.
19. Baril L, Nicolas L, Croisile B, Crozier P, Hessler C, et al. (2004) Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects. Neurosci Lett 355: 226-230.
20. Hyman BT, Smith C, Buldyrev I, Whelan C, Brown H, et al. (2001) Autoantibodies to amyloid-beta and Alzheimer's disease. Ann Neurol 49: 808-810.
21. Gustaw KA, Garrett MR, Lee H-G, Castellani RJ, Zagorski MG, et al. (2008) Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. J Neurochem 106: 1350-1356.
22. Gustaw-Rothenberg K, Siedlak S, Bonda D, (2010) Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study. Exp Gerontol 45: 47-52.
23. Klaver AC, Coffey MP, Smith LM, Bennett DA, Finke JM, et al. (2011) ELISA measurement of specific non-antigen-bound antibodies to Abeta1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects. J Neuroinflammation 8: 93.
24. Muhamuda K, Madhusudana SN, Ravi V, Desai A, (2006) Presence of rabies specific immune complexes in cerebro-spinal fluid can help in ante-mortem diagnosis of human paralytic rabies. J Clin Virol 37: 162-167.
25. Beneduce L, Prayer-Galetti T, Giustinian AMG, Gallotta A, Betto G, et al. (2007) Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Cancer Detecti Prev 31: 402-407.
26. Castaldi F, Marino M, Beneduce L, Belluco C, De Marchi F, et al. (2005) Detection of circulating CEA-IgM complexes in early stage colorectal cancer. I J Biol Markers 20: 204-208.
27. Przybylski M, Stefanescu R, Manea M, Perdivara I, Cozma C, et al. (2007) New molecular approaches for immunotherapy and diagnosis of Alzheimer's disease based on epitope-specific serum beta-amyloid antibodies. 7th Austral. Pept. Symposium, Cairns, abstr. p.32.
28. Dodel R, Bacher M, Przybylski M, Stefanescu R, Manea M (2008) Diagnosis of Alzheimer's disease and other neurodementing disorders. Patent International Application No.: PCT/IB2008/000456, Pub. No.: WO/2008/084402, European Patent Office.
29. McLaurin J, Cecal R, Kierstead ME, Tian X, Phinney AL, et al. (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat Med 8: 1263-1269.
30. Stefanescu R, Iacob RE, Damoc EN, Marquardt A, Amstalden E, et al. (2007) Mass spectrometric approaches for elucidation of antigenantibody recognition structures in molecular immunology. Eur J Mass Spectrom 13: 69-75.
31. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. 4th ed. te. Washington, DC: Author. 943 p.
32. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308.
33. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, et al. (2004) Mild cognitive impairment- beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256: 240-246.
34. Ackenheil M, Stotz-Ingenlath G, Dietz-Bauer R, Vossen A (1999) M.I.N.I. Mini Internationale Neuropsychiatric Interview (German version 5.0.0, DSM-IV). Munich: Psychiatric University Clinic.
35. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, et al. (1994) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 44: 609-614.
36. Tewes U (1991) Hamburg-Wechsler-Intelligenztest für Erwachsene- rev. ed. (HAWIE-R). Bern, Stuttgart, Toronto: Huber.
37. Steck PH, (2005) A revision of A. L. Benton's Visual Retention Test (BVRT) in two parallel forms. Arch Clin Neuropsychol 20: 409-416.
38. Manea M, Kalászi A, Mezo G, Horváti K, Bodor A, et al. (2008) Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regions. J Med Chem 51: 1150-1161.
39. Holm S, (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6: 65-70.
40. Pinheiro J, Bates D, DebRoy S, Sarkar D, the R Development Core Team (2011) nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-101. Available: http://cran.r-project.org/web/packages/nlme/citation.html. Accessed 24 May 2011.
41. Jianping L, Zhibing Y, Wei Q, Zhikai C, Jie X, et al. (2006) Low avidity and level of serum anti-Abeta antibodies in Alzheimer disease. Alzheimer Dis Assoc Disord 20: 127-132.